Related Experiment Video
Updated: Nov 17, 2025

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
Published on: May 20, 2016
Current Perspective on Nasal Delivery Systems for Chronic Rhinosinusitis
Junhu Tai1, Kijeong Lee1, Tae Hoon Kim1
1Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Korea University, Seoul 02841, Korea.
Topical nasal treatments are key for chronic rhinosinusitis. Research is exploring new agents and delivery methods to improve drug effectiveness for this upper respiratory disease.
Area of Science:
- Otorhinolaryngology
- Respiratory Medicine
- Pharmacology
Background:
- Chronic rhinosinusitis (CRS) is a prevalent upper respiratory disease.
- Topical nasal drug delivery is the primary therapeutic strategy for CRS.
- Current treatments include steroids, antibiotics, and antifungals, with ongoing research for novel agents.
Purpose of the Study:
- To review current and novel methods for nasal drug delivery in CRS management.
- To introduce recent advances and future perspectives in topical treatments for upper respiratory diseases.
Main Methods:
- Review of existing literature on chronic rhinosinusitis treatments.
- Analysis of factors influencing nasal drug delivery fluid dynamics (device, volume, compounds).
- Exploration of novel agents targeting bacterial biofilm and mucociliary clearance.
Main Results:
- Topical nasal drug delivery is crucial for CRS management.
- Nasal drug delivery efficacy is influenced by fluid dynamics, device, volume, and compounds.
- Research is advancing to improve bacterial biofilm disruption and mucociliary clearance.
Conclusions:
- Optimizing nasal drug delivery is essential for effective CRS treatment.
- Future research should focus on innovative compounds and delivery systems for upper respiratory diseases.
- Advances in fluid dynamics and agent development hold promise for improved CRS therapies.
More Related Videos
05:44Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery
Published on: November 14, 2018
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Suctioning the Nasopharyngeal Airway
Equipment Required
Inhaled Medications
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...